Zymeworks Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$23.14

+0.00 (+0.00%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -22.8% upside

Low Target $12.55

Average Target $17.86

High Target $20.90

Current Price $23.14

Current
$23.14

Target
$17.86

$12.55 $17.86 avg $20.90

Scenario Analysis

Bear Case

$12.55

-45.8%

Low target

Base Case

$17.86

-22.8%

Avg target

Bull Case

$20.90

+-9.7%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$29.75

-22.2% from high

52-Week Low

$11.51

+101.0% from low

Target vs 52W High

$17.86

-40.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.5%